Trial reportBMC anesthesiology2026
Effect of preoperative ultrasound-guided stellate ganglion block on pain thresholds and postoperative nausea and vomiting in gynecological laparoscopy: a randomised clinical trial.
Trial report in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
BACKGROUND AND
objectivesDespite advancements in laparoscopic techniques, postoperative pain and nausea/vomiting (PONV) remain primary barriers to optimal Enhanced Recovery After Surgery (ERAS) outcomes in gynecology. While stellate ganglion block (SGB) modulates autonomic function, its efficacy in elevating pain thresholds, reducing rescue medication use, and accelerating functional recovery requires robust evidence. This randomized trial evaluated whether preoperative SGB could refine these ERAS metrics.
methodsThis single-center randomized controlled trial included 84 patients undergoing elective gynecological laparoscopy, who were randomly allocated via computer-generated sequence to receive ultrasound-guided right-sided SGB (5 mL 0.25% ropivacaine at C6) or standard care. Primary endpoints were mechanical pain thresholds (von Frey filaments) and 48-h cumulative PONV incidence; secondary outcomes included VAS pain scores, rescue analgesic/antiemetic requirements, gastrointestinal recovery (time to first flatus/oral intake), and hospital stay.
resultsThe SGB group exhibited significantly higher mechanical pain thresholds at 24 h (P < 0.001) and a lower 48-h cumulative PONV incidence (24.4% vs. 48.8%, P = 0.036) compared to the Control group. Specifically, PONV incidence was significantly reduced during the 0–6 h, 7–12 h, and 13–24 h intervals (all P < 0.05), with no significant difference observed between 25 and 48 h (P = 0.713). Furthermore, the SGB group required significantly fewer rescue analgesics (31.7% vs. 55.8%, P = 0.026) and antiemetics (17.1% vs. 39.5%, P = 0.023), and achieved faster gastrointestinal recovery (first flatus and oral intake; both P < 0.01). No significant differences were found in 48-h pain thresholds or time to first ambulation (all P > 0.05). Transient Horner’s syndrome occurred in all SGB patients, with no severe complications reported.
conclusionsPreoperative SGB serves as a potent adjunct in gynecological ERAS protocols. By simultaneously elevating pain tolerance and curbing PONV, it facilitates a smoother and faster early recovery phase.
trial registrationChinese Clinical Trial Registry, ChiCTR2300068430. Registered 18 February 2023, http://www.chictr.org.cn/showproj.aspx?proj=189182 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.